Canadian Securities ExchangeThe Daily Bell

ME Therapeutics Holdings Inc.

ME Therapeutics Holdings Inc. (CSE:METX) is listed on the Canadian Securities Exchange in the Life Sciences sector, since October 12, 2023. The CSE has covered it in 2 stories and 4 CSE TV videos since 2025.

CSE:METXCompany profile on thecse.com

Also in these stories: Inflection Resources Ltd. (CSE:AUCU)

On CSE TV (4)

ME Therapeutics (CSE:METX)Engineering Immune Cells to Fight CancerJun 1, 2026
Targeting Immune Suppression in Cancer TreatmentIssuer Update (CSE:METX)Aug 18, 2025

Stories (2)

Jan 7, 2026CSE Issuer Stories

A Personal Mission to Reprogram the Human Immune Response to Cancer

Often when we discuss life sciences, particularly as investors, the human element gets lost. The focus tends to be on the pipeline, clinical and preclinical progress, data, efficacy, cash runway, and addressable market. These and other inputs can be plugged into a model to provide insight into a company’s chance of success. But this process…

ME Therapeutics Holdings Inc. (CSE:METX)

Dec 18, 2025Magazine

Canadian Securities Exchange Magazine: The Global Issue – Now Live!

Welcome to the latest issue of Canadian Securities Exchange Magazine, your source for in-depth stories of entrepreneurs from a wealth of different industries. The global capital markets map is being redrawn in real time. Economies are facing an inflection point: never before has the world been more interconnected through technology and trade; however, geopolitical tensions…

Inflection Resources Ltd. (CSE:AUCU)